4741 - 4750 of 9035 Results
Title
Year
-
RESTRICTEDTitle: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1201End Page: 1211Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00036Citation Count: 58
- Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells2019RESTRICTEDTitle: Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cellsJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 27Start Page: 12858End Page: 12870Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c9nr01277jCitation Count: 79
-
OPENTitle: IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page: e00065End Page: e00065Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://doi.org/10.1002/prp2.65Citation Count: 43
-
OPENTitle: Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 6Start Page: 1404End Page: 1406Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2018.08.016Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X18302997/pdfCitation Count: 9
-
OPENTitle: Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trialJournal Name: Stem Cell Research & TherapyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 493End Page: 493Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13287-025-04577-yBest OA location URL: https://stemcellres.biomedcentral.com/counter/pdf/10.1186/s13287-025-04577-yCitation Count: 3
-
OPENTitle: The Remote Assessment of Parkinsonism Supporting the Ongoing Development of Interventions in Gaucher DiseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 11Issue #: 6Start Page: 451End Page: 458Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2217/nmt-2021-0032Best OA location URL: https://doi.org/10.2217/nmt-2021-0032Citation Count: 15
-
OPENTitle: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian ratsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 174Issue #: 18Start Page: 3058End Page: 3071Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.13937Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5573415Citation Count: 24
- Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence Science2020OPENTitle: Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence ScienceJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 28Issue #: 6Start Page: 591End Page: 596Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.03.003Citation Count: 8
-
OPENTitle: Mining the neuroimaging literatureJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.94909Best OA location URL: https://elifesciences.org/reviewed-preprints/94909.pdfCitation Count: 1
-
OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 9